The pharmaceutical industry confronts a pivotal moment as the imperative to integrate sustainability throughout supply chains gains momentum. Amid shifting paradigms, companies are increasingly aware that business success is no longer measured solely in financial terms. Today's corporate climate
The quest for effective treatments in the fight against metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as non-alcoholic steatohepatitis (NASH), has reached an exciting new threshold. Boehringer Ingelheim has shared groundbreaking results from their Phase II clinical
In a significant move aimed at boosting the development of cell and gene therapies, Bionova Scientific, a part of the Asahi Kasei Group, has announced an ambitious $100 million investment. This investment will see the creation of a new state-of-the-art plasmid DNA (pDNA) production facility in The
In the rapidly-changing environment of the pharmaceutical industry, the innovative stride of Pharma 4.0 heralds a new era of drug production. This pivotal shift to smart manufacturing aligns with the principles of Industry 4.0, embedding digitalization and cutting-edge technology to meet the
Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic
In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a cautious stance
In an era where technology touches almost every aspect of our lives, mental health care has also experienced a digital transformation. Recent research sheds light on patient perspectives toward digital mental health technologies (DMHT). These tools, which range from mood tracking apps to meditation
In an industry where time-to-market is critical, a strategic collaboration between AGC Biologics, a global leader in biopharmaceutical development, and BioConnection, an aseptic filling expert, may be the key to unlocking faster pathways from laboratory to patient. As biotechnology firms grapple
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
Novo Holdings, a prominent Danish investment firm with a focus on life sciences, has recently cemented its standing in the biopharma manufacturing industry through a strategic acquisition. Securing a majority stake in Single Use Support, Novo Holdings ventures further into an increasingly vital
